Cargando…
Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness"
Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country level. Institutionalising robust deliberative processes requires significant time and resources, howe...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kerman University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384986/ https://www.ncbi.nlm.nih.gov/pubmed/28812807 http://dx.doi.org/10.15171/ijhpm.2016.118 |
_version_ | 1782520521135489024 |
---|---|
author | Chalkidou, Kalipso Li, Ryan Culyer, Anthony J. Glassman, Amanda Hofman, Karen J. Teerawattananon, Yot |
author_facet | Chalkidou, Kalipso Li, Ryan Culyer, Anthony J. Glassman, Amanda Hofman, Karen J. Teerawattananon, Yot |
author_sort | Chalkidou, Kalipso |
collection | PubMed |
description | Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country level. Institutionalising robust deliberative processes requires significant time and resources, however, and countries often begin by demanding evidence (including local CEA evidence as well as evidence about local values), whilst striving to strengthen the governance structures and technical capacities with which to generate, consider and act on such evidence. In low- and middle-income countries (LMICs), such capacities could be developed initially around a small technical unit in the health ministry or health insurer. The role of networks, development partners, and global norm setting organisations is crucial in supporting the necessary capacities. |
format | Online Article Text |
id | pubmed-5384986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Kerman University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-53849862017-04-11 Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness" Chalkidou, Kalipso Li, Ryan Culyer, Anthony J. Glassman, Amanda Hofman, Karen J. Teerawattananon, Yot Int J Health Policy Manag Commentary Cost-effectiveness analysis (CEA) can help countries attain and sustain universal health coverage (UHC), as long as it is context-specific and considered within deliberative processes at the country level. Institutionalising robust deliberative processes requires significant time and resources, however, and countries often begin by demanding evidence (including local CEA evidence as well as evidence about local values), whilst striving to strengthen the governance structures and technical capacities with which to generate, consider and act on such evidence. In low- and middle-income countries (LMICs), such capacities could be developed initially around a small technical unit in the health ministry or health insurer. The role of networks, development partners, and global norm setting organisations is crucial in supporting the necessary capacities. Kerman University of Medical Sciences 2016-08-29 /pmc/articles/PMC5384986/ /pubmed/28812807 http://dx.doi.org/10.15171/ijhpm.2016.118 Text en © 2017 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Chalkidou, Kalipso Li, Ryan Culyer, Anthony J. Glassman, Amanda Hofman, Karen J. Teerawattananon, Yot Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness" |
title | Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness" |
title_full | Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness" |
title_fullStr | Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness" |
title_full_unstemmed | Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness" |
title_short | Health Technology Assessment: Global Advocacy and Local Realities: Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness" |
title_sort | health technology assessment: global advocacy and local realities: comment on "priority setting for universal health coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness" |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384986/ https://www.ncbi.nlm.nih.gov/pubmed/28812807 http://dx.doi.org/10.15171/ijhpm.2016.118 |
work_keys_str_mv | AT chalkidoukalipso healthtechnologyassessmentglobaladvocacyandlocalrealitiescommentonprioritysettingforuniversalhealthcoverageweneedevidenceinformeddeliberativeprocessesnotjustmoreevidenceoncosteffectiveness AT liryan healthtechnologyassessmentglobaladvocacyandlocalrealitiescommentonprioritysettingforuniversalhealthcoverageweneedevidenceinformeddeliberativeprocessesnotjustmoreevidenceoncosteffectiveness AT culyeranthonyj healthtechnologyassessmentglobaladvocacyandlocalrealitiescommentonprioritysettingforuniversalhealthcoverageweneedevidenceinformeddeliberativeprocessesnotjustmoreevidenceoncosteffectiveness AT glassmanamanda healthtechnologyassessmentglobaladvocacyandlocalrealitiescommentonprioritysettingforuniversalhealthcoverageweneedevidenceinformeddeliberativeprocessesnotjustmoreevidenceoncosteffectiveness AT hofmankarenj healthtechnologyassessmentglobaladvocacyandlocalrealitiescommentonprioritysettingforuniversalhealthcoverageweneedevidenceinformeddeliberativeprocessesnotjustmoreevidenceoncosteffectiveness AT teerawattananonyot healthtechnologyassessmentglobaladvocacyandlocalrealitiescommentonprioritysettingforuniversalhealthcoverageweneedevidenceinformeddeliberativeprocessesnotjustmoreevidenceoncosteffectiveness |